The Advantage of Pinpoint Camera System With Indocyanine Green for Sentinel Lymph Node Micrometastasis Detection in Low Risk Endometrial Cancer.
Endometrial cancer
PinPoint camera system
indocyanine green
laparoscopy
lymphadenectomy
sentinel lymph node
Journal
In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809
Informations de publication
Date de publication:
Historique:
received:
29
09
2020
revised:
09
12
2020
accepted:
15
12
2020
entrez:
24
2
2021
pubmed:
25
2
2021
medline:
22
6
2021
Statut:
ppublish
Résumé
This report outlines our experience in the management of 10 cases of low-risk endometrial cancer with Indocyanine Green for sentinel lymph node (SLN) mapping using the Pinpoint 30-degree 4K S1 SPY real-time camera system (Stryker). This system offers simultaneous, real-time, high-definition white light and fluorescence imaging through a single laparoscope, without the need to change camera filters. In our retrospective case series we included all endometrioid endometrial cancers of grade G1 and pre-operative radiological staging FIGO 1A reported on magnetic resonance imaging (MRI) that were treated laparoscopically from October 2019 to April 2020. Bilateral sentinel lymph node excision was achieved in 9 out of 10 cases. In one patient, one sentinel lymph node featuring a micrometastasis of <2 mm was identified. A specialist minimal access team can safely and reliably reproduce this technique for sentinel lymph node excision.
Sections du résumé
BACKGROUND/AIM
OBJECTIVE
This report outlines our experience in the management of 10 cases of low-risk endometrial cancer with Indocyanine Green for sentinel lymph node (SLN) mapping using the Pinpoint 30-degree 4K S1 SPY real-time camera system (Stryker). This system offers simultaneous, real-time, high-definition white light and fluorescence imaging through a single laparoscope, without the need to change camera filters.
PATIENTS AND METHODS
METHODS
In our retrospective case series we included all endometrioid endometrial cancers of grade G1 and pre-operative radiological staging FIGO 1A reported on magnetic resonance imaging (MRI) that were treated laparoscopically from October 2019 to April 2020.
RESULTS
RESULTS
Bilateral sentinel lymph node excision was achieved in 9 out of 10 cases. In one patient, one sentinel lymph node featuring a micrometastasis of <2 mm was identified.
CONCLUSION
CONCLUSIONS
A specialist minimal access team can safely and reliably reproduce this technique for sentinel lymph node excision.
Identifiants
pubmed: 33622899
pii: 35/2/1033
doi: 10.21873/invivo.12347
pmc: PMC8045059
doi:
Substances chimiques
Coloring Agents
0
Indocyanine Green
IX6J1063HV
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1033-1039Informations de copyright
Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Références
Gynecol Oncol. 2012 Jul;126(1):5-11
pubmed: 22555109
Lancet. 2009 Jan 10;373(9658):125-36
pubmed: 19070889
Lancet Oncol. 2010 Aug;11(8):772-80
pubmed: 20638899
Gynecol Oncol. 2015 Jun;137(3):436-42
pubmed: 25870917
Gynecol Oncol. 2015 Aug;138(2):478-85
pubmed: 26047592
Gynecol Oncol. 2014 May;133(2):274-7
pubmed: 24582865
Oncologist. 2016 Apr;21(4):461-6
pubmed: 26961924
Wien Klin Wochenschr. 1956 Mar 23;68(12):247-8
pubmed: 13338265
Cancer. 2006 Oct 15;107(8):1823-30
pubmed: 16977653
Gynecol Oncol. 2012 Jun;125(3):531-5
pubmed: 22366409
Int J Cancer. 2010 Dec 15;127(12):2893-917
pubmed: 21351269
J Clin Oncol. 2009 Nov 10;27(32):5331-6
pubmed: 19805679
J Clin Oncol. 2005 Jun 1;23(16):3668-75
pubmed: 15738538
BMJ Open. 2013 Apr 18;3(4):
pubmed: 23604345
Ann Oncol. 2016 Jan;27(1):16-41
pubmed: 26634381
Gynecol Oncol. 2012 Jan;124(1):78-82
pubmed: 21996262
Gynecol Oncol. 2012 Mar;124(3):496-501
pubmed: 22120175
J Cancer Res Clin Oncol. 2020 Dec;146(12):3199-3205
pubmed: 32815026
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Gynecol Oncol. 2013 Apr;129(1):38-41
pubmed: 23321065
Br J Cancer. 2011 Dec 6;105 Suppl 2:S77-81
pubmed: 22158327
Eur J Surg Oncol. 2019 Sep;45(9):1638-1643
pubmed: 31229377
Lancet. 2010 Apr 3;375(9721):1165-72
pubmed: 20188410
Gynecol Oncol. 2009 Oct;115(1):142-153
pubmed: 19592079
Gynecol Oncol. 2016 Mar;140(3):394-9
pubmed: 26747778
Lancet Oncol. 2011 May;12(5):469-76
pubmed: 21489874
Gynecol Oncol. 2011 Oct;123(1):65-70
pubmed: 21742369
Clin Transl Oncol. 2020 Aug;22(8):1272-1279
pubmed: 31863354
Lancet Oncol. 2017 Mar;18(3):384-392
pubmed: 28159465
Gynecol Oncol. 2017 Aug;146(2):405-415
pubmed: 28566221
Ann Surg Oncol. 2016 Jul;23(7):2183-91
pubmed: 26714944
Gynecol Oncol. 2015 Jun;137(3):443-7
pubmed: 25771495